FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1970082198> ?p ?o ?g. }

• W1970082198 abstract "Artemisinin, from which the artemether component of Coartem (artemether/lumefantrine, AL) is derived, is obtained from the plant sweet wormwood (Artemisia annua) which has been used for over 2,000 years as a Chinese herbal remedy. Artemisinin was first identified by Chinese researchers as the active anti-malarial constituent of A. annua and its derivatives were found to be the most potent of all anti-malarial drugs. Artemether acts rapidly, reducing the infecting parasite biomass by approximately 10,000-fold per asexual life cycle. Lumefantrine, the other active constituent of AL, acts over a longer period to eliminate the residual 100-100,000 parasites that remain after artemether is cleared from the body and thus minimizes the risk of recrudescence. The two agents have different modes of action and act at different points in the parasite life cycle and show a synergistic action against Plasmodium falciparum in vitro. The combination of artemether and lumefantrine reduces the risk of resistance developing to either agent, and to date there are no reports of resistance to AL combined therapy in the malaria parasite that infects humans. Following a unique partnership agreement between Chinese authorities and Novartis, the manufacturer of AL, over 20 sponsored clinical studies have been undertaken in various malaria endemic regions and in travellers. These trials have involved more than 3,500 patients (including over 2,000 children), and led to identification of a six-dose, three-day regimen as the optimal dosing strategy for AL in uncomplicated falciparum malaria. AL has consistently shown 28-day polymerase chain (PCR)-corrected cure rates greater than 95% in the evaluable population, meeting WHO recommendations. More recently, Novartis and the Medicines for Malaria Venture have worked in partnership to develop Coartem Dispersible, a new formulation designed specifically to meet the specific needs of children with malaria. The dispersible tablets have shown similar high response rates to those observed with crushed standard tablets of AL. A partnership agreement between Novartis and WHO has seen over 250 million AL (Coartem) treatments (75% for children) being distributed to malaria patients in developing countries without profit, supported by training programmes and educational resources." @default.
• W1970082198 created "2016-06-24" @default.
• W1970082198 creator A5085519709 @default.
• W1970082198 date "2009-10-12" @default.
• W1970082198 modified "2023-10-13" @default.
• W1970082198 title "Coartem®: the journey to the clinic" @default.
• W1970082198 cites W1963728755 @default.
• W1970082198 cites W1978163612 @default.
• W1970082198 cites W2000755789 @default.
• W1970082198 cites W2023948728 @default.
• W1970082198 cites W2026191774 @default.
• W1970082198 cites W2029555742 @default.
• W1970082198 cites W2040713555 @default.
• W1970082198 cites W2051456573 @default.
• W1970082198 cites W2075493950 @default.
• W1970082198 cites W2076029682 @default.
• W1970082198 cites W2083606760 @default.
• W1970082198 cites W2090726723 @default.
• W1970082198 cites W2095518262 @default.
• W1970082198 cites W2095621718 @default.
• W1970082198 cites W2097760506 @default.
• W1970082198 cites W2120286781 @default.
• W1970082198 cites W2120622726 @default.
• W1970082198 cites W2123618955 @default.
• W1970082198 cites W2124106345 @default.
• W1970082198 cites W2124606437 @default.
• W1970082198 cites W2127272111 @default.
• W1970082198 cites W2127807805 @default.
• W1970082198 cites W2134089025 @default.
• W1970082198 cites W2136255204 @default.
• W1970082198 cites W2142025416 @default.
• W1970082198 cites W2148126720 @default.
• W1970082198 cites W2149251475 @default.
• W1970082198 cites W2161510631 @default.
• W1970082198 cites W2171031967 @default.
• W1970082198 cites W2292986559 @default.
• W1970082198 cites W2409453749 @default.
• W1970082198 doi "https://doi.org/10.1186/1475-2875-8-s1-s3" @default.
• W1970082198 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2760238" @default.
• W1970082198 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19818170" @default.
• W1970082198 hasPublicationYear "2009" @default.
• W1970082198 type Work @default.
• W1970082198 sameAs 1970082198 @default.
• W1970082198 citedByCount "47" @default.
• W1970082198 countsByYear W19700821982012 @default.
• W1970082198 countsByYear W19700821982013 @default.
• W1970082198 countsByYear W19700821982014 @default.
• W1970082198 countsByYear W19700821982015 @default.
• W1970082198 countsByYear W19700821982016 @default.
• W1970082198 countsByYear W19700821982017 @default.
• W1970082198 countsByYear W19700821982018 @default.
• W1970082198 countsByYear W19700821982020 @default.
• W1970082198 countsByYear W19700821982021 @default.
• W1970082198 countsByYear W19700821982022 @default.
• W1970082198 countsByYear W19700821982023 @default.
• W1970082198 crossrefType "journal-article" @default.
• W1970082198 hasAuthorship W1970082198A5085519709 @default.
• W1970082198 hasBestOaLocation W19700821981 @default.
• W1970082198 hasConcept C203014093 @default.
• W1970082198 hasConcept C2776120307 @default.
• W1970082198 hasConcept C2778048844 @default.
• W1970082198 hasConcept C2778118209 @default.
• W1970082198 hasConcept C2778371730 @default.
• W1970082198 hasConcept C2778629330 @default.
• W1970082198 hasConcept C2779691961 @default.
• W1970082198 hasConcept C2780780316 @default.
• W1970082198 hasConcept C556039675 @default.
• W1970082198 hasConcept C71924100 @default.
• W1970082198 hasConcept C98274493 @default.
• W1970082198 hasConceptScore W1970082198C203014093 @default.
• W1970082198 hasConceptScore W1970082198C2776120307 @default.
• W1970082198 hasConceptScore W1970082198C2778048844 @default.
• W1970082198 hasConceptScore W1970082198C2778118209 @default.
• W1970082198 hasConceptScore W1970082198C2778371730 @default.
• W1970082198 hasConceptScore W1970082198C2778629330 @default.
• W1970082198 hasConceptScore W1970082198C2779691961 @default.
• W1970082198 hasConceptScore W1970082198C2780780316 @default.
• W1970082198 hasConceptScore W1970082198C556039675 @default.
• W1970082198 hasConceptScore W1970082198C71924100 @default.
• W1970082198 hasConceptScore W1970082198C98274493 @default.
• W1970082198 hasIssue "S1" @default.
• W1970082198 hasLocation W19700821981 @default.
• W1970082198 hasLocation W19700821982 @default.
• W1970082198 hasLocation W19700821983 @default.
• W1970082198 hasLocation W19700821984 @default.
• W1970082198 hasOpenAccess W1970082198 @default.
• W1970082198 hasPrimaryLocation W19700821981 @default.
• W1970082198 hasRelatedWork W1044842490 @default.
• W1970082198 hasRelatedWork W1968114154 @default.
• W1970082198 hasRelatedWork W1970082198 @default.
• W1970082198 hasRelatedWork W2110269548 @default.
• W1970082198 hasRelatedWork W2133922592 @default.
• W1970082198 hasRelatedWork W2137636253 @default.
• W1970082198 hasRelatedWork W2585110111 @default.
• W1970082198 hasRelatedWork W2608258486 @default.
• W1970082198 hasRelatedWork W3004753694 @default.
• W1970082198 hasRelatedWork W3179314929 @default.
• W1970082198 hasVolume "8" @default.
• W1970082198 isParatext "false" @default.
• W1970082198 isRetracted "false" @default.

• next